Location History:
- Caledonia, NY (US) (2010 - 2012)
- Avon, NY (US) (2012)
Company Filing History:
Years Active: 2010-2012
Title: The Innovations of Daniel G Hullihen
Introduction
Daniel G Hullihen is a notable inventor based in Caledonia, NY (US). He has made significant contributions to the field of medical devices, particularly in the development of advanced stents and targeted therapeutic delivery systems. With a total of 3 patents to his name, Hullihen's work has the potential to greatly enhance patient care and treatment outcomes.
Latest Patents
One of Hullihen's latest patents is for a medicated stent having a multi-layer polymer coating. This invention relates to stents that feature medicated multi-layer hybrid polymer coatings, which are useful for treating stenosed vasculature or other body passages. Another significant patent focuses on targeted therapeutic agent release devices and methods for making and using them. This invention provides devices and methods for delivering high concentrations of therapeutic agents, such as drugs and antibiotics, to specific sites in a patient's body, including tumors and infected lesions. The devices are designed to be positioned in the body using minimally invasive techniques, such as catheterization or via trochar, ensuring effective treatment with reduced patient discomfort.
Career Highlights
Hullihen is currently associated with Angiotech Biocoatings, Inc., where he continues to innovate in the medical device sector. His work has been instrumental in advancing the technology behind drug delivery systems and improving the efficacy of medical treatments.
Collaborations
Throughout his career, Hullihen has collaborated with notable colleagues, including Richard J Whitbourne and Alexandra M Chamberlain. These partnerships have contributed to the development of groundbreaking medical technologies.
Conclusion
Daniel G Hullihen's contributions to the field of medical devices exemplify the impact of innovation on healthcare. His patents reflect a commitment to improving patient outcomes through advanced technology.